Pfizer Inc. plans an initial public offering of a minority stake in its animal health business to pay off debt.
The long-anticipated offering by the world’s largest drugmaker will represent up to a 20 percent ownership stake in the animal health business, which it named Zoetis. A regulatory filing with the Securities and Exchange Commission does not detail the size of the offering or the anticipated share price.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.